A total of 130 primary cases with superficial bladder cancer were entered in the prospective randomized group study. The prophylactic treatments compared consisted in intravesical instillation of adriamycin (20 mg/-40 ml or 30 mg/30 ml), mitomycin C (20 mg/40 ml) or thio-TEPA (30 mg/30 ml), and noni
β¦ LIBER β¦
Incidence of infiltrating cancer following superficial bladder carcinoma
β Scribed by Fabio Levi; Carlo La Vecchia; Lalao Randimbison; Silvia Franceschi
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- French
- Weight
- 344 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Prophylactic treatment for superficial b
β
Yoshihiko Hirao; Eigoro Okajima; Soichi Ohara; Seiichiro Ozono; Tadashi Hiramats
π
Article
π
1987
π
Springer
π
English
β 455 KB
Treatment of superficial carcinoma of th
β
David F. Paulson
π
Article
π
1986
π
Springer-Verlag
π
English
β 717 KB
Intravesical treatment of superficial bl
β
Bernd J. Schmitz-DrΓ€ger; Thomas Ebert; Rolf Ackermann
π
Article
π
1986
π
Springer-Verlag
π
English
β 575 KB
Treatment of superficial bladder cancer
β
Robert A. Badalament; Riad N. Farah
π
Article
π
1997
π
John Wiley and Sons
π
English
β 51 KB
π 2 views
Proper care of patients with superficial bladder cancer requires the assessment of multiple factors, including an understanding of the natural history of this disease, accurate clinical staging, and the expected efficacy of each drug. The pharmacology of intravesical mytomycin C is discussed in deta
Strategy for improving therapy of superf
β
T. L. Ratliff; M. A. Hudson; W. J. Catalona
π
Article
π
1991
π
Springer-Verlag
π
English
β 456 KB
The role of adjunctive immunotherapy in
β
Kimio Fujita
π
Article
π
1987
π
John Wiley and Sons
π
English
β 304 KB
π 2 views